ArticleAsia Pacific allergy2024

Does omalizumab increase the risk of malignancy? A retrospective case-control study in a single tertiary hospital.

Hyun Jee Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.